COVID-19 Impact on In Vitro Diagnostic/IVD Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on In Vitro Diagnostic/IVD Industry
1.7 COVID-19 Impact: In Vitro Diagnostic/IVD Market Trends
2 Global In Vitro Diagnostic/IVD Quarterly Market Size Analysis
2.1 In Vitro Diagnostic/IVD Business Impact Assessment - COVID-19
2.1.1 Global In Vitro Diagnostic/IVD Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global In Vitro Diagnostic/IVD Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global In Vitro Diagnostic/IVD Quarterly Market Size, 2019 VS 2020
3.2 By Players, In Vitro Diagnostic/IVD Headquarters and Area Served
3.3 Date of Key Players Enter into In Vitro Diagnostic/IVD Market
3.4 Key Players In Vitro Diagnostic/IVD Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on In Vitro Diagnostic/IVD Segments, By Type
4.1 Introduction
1.4.1 Instruments
1.4.2 Reagents
4.2 By Type, Global In Vitro Diagnostic/IVD Market Size, 2019-2021
5 Impact of Covid-19 on In Vitro Diagnostic/IVD Segments, By Application
5.1 Overview
5.5.1 Diabetes
5.5.2 Oncology
5.5.3 Cardiology
5.5.4 Nephrology
5.2 By Application, Global In Vitro Diagnostic/IVD Market Size, 2019-2021
5.2.1 By Application, Global In Vitro Diagnostic/IVD Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Roche Diagnostics (Switzerland)
7.1.1 Roche Diagnostics (Switzerland) Business Overview
7.1.2 Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Quarterly Revenue, 2020
7.1.3 Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Product Introduction
7.1.4 Roche Diagnostics (Switzerland) Response to COVID-19 and Related Developments
7.2 Siemens Healthineers (Germany)
7.2.1 Siemens Healthineers (Germany) Business Overview
7.2.2 Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Quarterly Revenue, 2020
7.2.3 Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Product Introduction
7.2.4 Siemens Healthineers (Germany) Response to COVID-19 and Related Developments
7.3 Danaher Corporation (US)
7.3.1 Danaher Corporation (US) Business Overview
7.3.2 Danaher Corporation (US) In Vitro Diagnostic/IVD Quarterly Revenue, 2020
7.3.3 Danaher Corporation (US) In Vitro Diagnostic/IVD Product Introduction
7.3.4 Danaher Corporation (US) Response to COVID-19 and Related Developments
7.4 Abbott Laboratories (US)
7.4.1 Abbott Laboratories (US) Business Overview
7.4.2 Abbott Laboratories (US) In Vitro Diagnostic/IVD Quarterly Revenue, 2020
7.4.3 Abbott Laboratories (US) In Vitro Diagnostic/IVD Product Introduction
7.4.4 Abbott Laboratories (US) Response to COVID-19 and Related Developments
7.5 Thermo Fisher Scientific (US)
7.5.1 Thermo Fisher Scientific (US) Business Overview
7.5.2 Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Quarterly Revenue, 2020
7.5.3 Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Product Introduction
7.5.4 Thermo Fisher Scientific (US) Response to COVID-19 and Related Developments
7.6 Johnson and Johnson (US)
7.6.1 Johnson and Johnson (US) Business Overview
7.6.2 Johnson and Johnson (US) In Vitro Diagnostic/IVD Quarterly Revenue, 2020
7.6.3 Johnson and Johnson (US) In Vitro Diagnostic/IVD Product Introduction
7.6.4 Johnson and Johnson (US) Response to COVID-19 and Related Developments
7.7 Bio-Rad Laboratories (US)
7.7.1 Bio-Rad Laboratories (US) Business Overview
7.7.2 Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Quarterly Revenue, 2020
7.7.3 Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Product Introduction
7.7.4 Bio-Rad Laboratories (US) Response to COVID-19 and Related Developments
7.8 Sysmex Corporation (Japan)
7.8.1 Sysmex Corporation (Japan) Business Overview
7.8.2 Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Quarterly Revenue, 2020
7.8.3 Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Product Introduction
7.8.4 Sysmex Corporation (Japan) Response to COVID-19 and Related Developments
7.9 bioMérieux (France)
7.9.1 bioMérieux (France) Business Overview
7.9.2 bioMérieux (France) In Vitro Diagnostic/IVD Quarterly Revenue, 2020
7.9.3 bioMérieux (France) In Vitro Diagnostic/IVD Product Introduction
7.9.4 bioMérieux (France) Response to COVID-19 and Related Developments
7.10 DiaSorin (Italy)
7.10.1 DiaSorin (Italy) Business Overview
7.10.2 DiaSorin (Italy) In Vitro Diagnostic/IVD Quarterly Revenue, 2020
7.10.3 DiaSorin (Italy) In Vitro Diagnostic/IVD Product Introduction
7.10.4 DiaSorin (Italy) Response to COVID-19 and Related Developments
7.11 Ortho Clinical Diagnostics (US)
7.11.1 Ortho Clinical Diagnostics (US) Business Overview
7.11.2 Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Quarterly Revenue, 2020
7.11.3 Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Product Introduction
7.11.4 Ortho Clinical Diagnostics (US) Response to COVID-19 and Related Developments
7.12 Agilent Technologies (US)
7.12.1 Agilent Technologies (US) Business Overview
7.12.2 Agilent Technologies (US) In Vitro Diagnostic/IVD Quarterly Revenue, 2020
7.12.3 Agilent Technologies (US) In Vitro Diagnostic/IVD Product Introduction
7.12.4 Agilent Technologies (US) Response to COVID-19 and Related Developments
7.13 QIAGEN (Germany)
7.13.1 QIAGEN (Germany) Business Overview
7.13.2 QIAGEN (Germany) In Vitro Diagnostic/IVD Quarterly Revenue, 2020
7.13.3 QIAGEN (Germany) In Vitro Diagnostic/IVD Product Introduction
7.13.4 QIAGEN (Germany) Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on In Vitro Diagnostic/IVD Assessment
Table 9. COVID-19 Impact: In Vitro Diagnostic/IVD Market Trends
Table 10. COVID-19 Impact Global In Vitro Diagnostic/IVD Market Size
Table 11. Global In Vitro Diagnostic/IVD Quarterly Market Size, 2020 (US$ Million)
Table 12. Global In Vitro Diagnostic/IVD Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global In Vitro Diagnostic/IVD Market Growth Drivers
Table 14. Global In Vitro Diagnostic/IVD Market Restraints
Table 15. Global In Vitro Diagnostic/IVD Market Opportunities
Table 16. Global In Vitro Diagnostic/IVD Market Challenges
Table 17. By Players, In Vitro Diagnostic/IVD Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, In Vitro Diagnostic/IVD Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key In Vitro Diagnostic/IVD Players Headquarters and Area Served
Table 20. Date of Key Players Enter into In Vitro Diagnostic/IVD Market
Table 21. Key Players In Vitro Diagnostic/IVD Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global In Vitro Diagnostic/IVD Market Size 2019-2021, (US$ Million)
Table 24. Global In Vitro Diagnostic/IVD Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global In Vitro Diagnostic/IVD Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa In Vitro Diagnostic/IVD Market Size, 2019-2021 (US$ Million)
Table 57. Roche Diagnostics (Switzerland) Business Overview
Table 58. Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Product
Table 60. Roche Diagnostics (Switzerland) Response to COVID-19 and Related Developments
Table 61. Siemens Healthineers (Germany) Business Overview
Table 62. Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Product
Table 64. Siemens Healthineers (Germany) Response to COVID-19 and Related Developments
Table 65. Danaher Corporation (US) Business Overview
Table 66. Danaher Corporation (US) In Vitro Diagnostic/IVD Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Danaher Corporation (US) In Vitro Diagnostic/IVD Product
Table 68. Danaher Corporation (US) Response to COVID-19 and Related Developments
Table 69. Abbott Laboratories (US) Business Overview
Table 70. Abbott Laboratories (US) In Vitro Diagnostic/IVD Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Abbott Laboratories (US) In Vitro Diagnostic/IVD Product
Table 72. Abbott Laboratories (US) Response to COVID-19 and Related Developments
Table 73. Thermo Fisher Scientific (US) Business Overview
Table 74. Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Product
Table 76. Thermo Fisher Scientific (US) Response to COVID-19 and Related Developments
Table 77. Johnson and Johnson (US) Business Overview
Table 78. Johnson and Johnson (US) In Vitro Diagnostic/IVD Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Johnson and Johnson (US) In Vitro Diagnostic/IVD Product
Table 80. Johnson and Johnson (US) Response to COVID-19 and Related Developments
Table 81. Bio-Rad Laboratories (US) Business Overview
Table 82. Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Product
Table 84. Bio-Rad Laboratories (US) Response to COVID-19 and Related Developments
Table 85. Sysmex Corporation (Japan) Business Overview
Table 86. Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Product
Table 88. Sysmex Corporation (Japan) Response to COVID-19 and Related Developments
Table 89. bioMérieux (France) Business Overview
Table 90. bioMérieux (France) In Vitro Diagnostic/IVD Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. bioMérieux (France) In Vitro Diagnostic/IVD Product
Table 92. bioMérieux (France) Response to COVID-19 and Related Developments
Table 93. DiaSorin (Italy) Business Overview
Table 94. DiaSorin (Italy) In Vitro Diagnostic/IVD Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. DiaSorin (Italy) In Vitro Diagnostic/IVD Product
Table 96. DiaSorin (Italy) Response to COVID-19 and Related Developments
Table 97. Ortho Clinical Diagnostics (US) Business Overview
Table 98. Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Product
Table 100. Ortho Clinical Diagnostics (US) Response to COVID-19 and Related Developments
Table 101. Agilent Technologies (US) Business Overview
Table 102. Agilent Technologies (US) In Vitro Diagnostic/IVD Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Agilent Technologies (US) In Vitro Diagnostic/IVD Product
Table 104. Agilent Technologies (US) Response to COVID-19 and Related Developments
Table 105. QIAGEN (Germany) Business Overview
Table 106. QIAGEN (Germany) In Vitro Diagnostic/IVD Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. QIAGEN (Germany) In Vitro Diagnostic/IVD Product
Table 108. QIAGEN (Germany) Response to COVID-19 and Related Developments
List of FiguresFigure 1. In Vitro Diagnostic/IVD Product Picture
Figure 2. In Vitro Diagnostic/IVD Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global In Vitro Diagnostic/IVD Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global In Vitro Diagnostic/IVD Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global In Vitro Diagnostic/IVD Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global In Vitro Diagnostic/IVD Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global In Vitro Diagnostic/IVD Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global In Vitro Diagnostic/IVD Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific In Vitro Diagnostic/IVD Market Size Market Share, 2019-2021